GSRX Industries Inc. CEO Les Ball Interviewed on Uptick Newswire’s Stock Day Podcast
DORADO, Puerto Rico, Nov. 09, 2018 (GLOBE NEWSWIRE) — GSRX Industries Inc. (OTCQB: GSRX) (“GSRX” or the “Company”) today announced that Les Ball, CEO, was a featured guest on Uptick Newswire’s Stock Day Podcast on Tuesday, November 6. The complete interview can be heard at Uptick Newswire.
In the interview conducted by Everett Jolly, CEO of Uptick Newswire, Ball reviewed GSRX’s recently announced third quarter financial results, which reflected total revenues of $706,428, an increase of 100% in quarter-over-quarter revenue.
During the interview, Ball provided updates on the Company’s businesses, which are led by an experienced management team, as well as a look toward the immediate future. Some highlights include:
- an update on the Company’s retail dispensary businesses, which include four locations in Puerto Rico and one in Northern California;
- an update on the Company’s majority-owned subsidiary, San Francisco-based extraction and manufacturing company Spirulinex, LLC, whose patent-pending flagship product, Dragonglass™, is a superfood-based sub-lingual flake available in both THC and CBD formulations;
- plans to operate up to 11 dispensaries in the near future; and
- growth opportunities and expansion plans for fiscal year 2019.
About GSRX Industries Inc.
GSRX Industries Inc. (OTCQB: GSRX), through its subsidiaries, is in the business of acquiring, developing and operating retail cannabis dispensaries, and is in the process of expanding its business to include the cultivation, extraction, manufacture and delivery of cannabis and cannabinoid products. Currently, GSRX operates five cannabis dispensaries in California and Puerto Rico, and has six additional pre-qualified locations in Puerto Rico, all of which are in various phases of development and construction.
Green Spirit RX (Puerto Rico) https://www.facebook.com/Green-Spirit-Rx-746194692378429/
The Green Room https://www.facebook.com/greenroommendo/
This press release contains forward-looking statements. Such statements include statements regarding our expectations, hopes, beliefs or intentions regarding the future, including but not limited to statements regarding our market, strategy, competition, development plans (including acquisitions and expansion), financing, revenues, operations, and compliance with applicable laws. Forward-looking statements involve certain risks and uncertainties, and actual results may differ materially from those discussed in any such statement. Factors that could cause actual results to differ materially from such forward-looking statements include the risks described in greater detail in the following paragraphs. All forward-looking statements in this document are made as of the date hereof, based on information available to us as of the date hereof, and we assume no obligation to update any forward-looking statement except where applicable law requires us to update these statements. Market data used throughout this prospectus is based on published third party reports or the good faith estimates of management, which estimates are based upon their review of internal surveys, independent industry publications and other publicly available information.
Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection there with. If you are affiliated with this page and would like it removed please contact [email protected]